Loughborough UniversityBrowse
fmicb-11-584137 final published version.pdf (112.69 kB)
Download file

Editorial: Manufacturing, formulation and delivery issues for phage therapy to become a reality

Download (112.69 kB)
journal contribution
posted on 29.03.2021, 09:24 by Danish MalikDanish Malik, Gregory Resch
Editorial on the research topic: Manufacturing, formulation and delivery issues for phage therapy to become a reality.

History

School

  • Aeronautical, Automotive, Chemical and Materials Engineering

Department

  • Chemical Engineering

Published in

Frontiers in Microbiology

Volume

11

Publisher

Frontiers Media

Version

VoR (Version of Record)

Rights holder

© The Authors

Publisher statement

This is an Open Access Article. It is published by Frontiers Media under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0). Full details of this licence are available at: https://creativecommons.org/licenses/by/4.0/

Acceptance date

31/08/2020

Publication date

2020-10-08

Copyright date

2020

DOI

ISSN

1664-302X

eISSN

1664-302X

Publisher version

Language

en

Depositor

Dr Danish Malik. Deposit date: 22 March 2021

Article number

584137

Usage metrics

Read the paper on the publisher website

Editorial: Manufacturing, formulation and delivery issues for phage therapy to become a reality
Loughborough PublicationsLoughborough Publications

Categories

Keywords

bacteriophage therapyquality-by-design (QbD)cGMP Manufactureupstream process (USP)downstream process (DSP)bacteriophagesantibiotic resistanceformulationstabilityformulation/stability

Licence

CC BY 4.0

Exports